Novo Nordisk, the Denmark-based diabetes drug producer, is planning to commence clinical trials for Aerx, an insulin inhaler, in India. Anil Kapur, managing director of Novo Dordisk India, said:
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Novo Nordisk, the Denmark-based diabetes drug producer, is planning to commence clinical trials for Aerx, an insulin inhaler, in India. Anil Kapur, managing director of Novo Dordisk India, said:
First Published: Dec 04 2002 | 12:00 AM IST